FIELD: medicine.
SUBSTANCE: the present innovation deals with applying compounds being united selective inhibitors of serotonin reverse capture (5-HT) (SSRI) and agonists of 5-HT1a receptor, especially 1-[4-(5-cyanoindole-3-il)butyl]-4-(2-carbamoyl-benzofuran-5-il)-piperazine or its physiologically acceptable salt, or 3-{4-[4-(4-cyanophenyl)-piperazine-1-il]-butyl}- 1H-indole-5-carbonitrile or its physiologically acceptable salt, in particular, hydrochloride, for manufacturing preparation for treating inflammatory bowel syndrome (IBS) The innovation decreases the symptoms of IBS: spastic pains, meteorism, painful constipation or diarrhea.
EFFECT: higher efficiency.
3 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USING COMPOUND COMBINING PROPERTY OF SEROTONIN REVERSE UPTAKE INHIBITOR AND AGONIST OF 5-HT-RECEPTOR | 2001 |
|
RU2288719C2 |
| NEW APPLICATION OF 1-[4-(5-CYANOINDOL-3-YL)BUTYL]-4-(2-CARBAMOYLBENZOFURANE-5-YL)-PIPERAZINE AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS | 2000 |
|
RU2237477C2 |
| AGONISM OF 5НТ-RECEPTOR FOR TREATMENT OF DISTURBANCE OF THERMOREGULATION FUNCTION | 2003 |
|
RU2340333C2 |
| 5-(4-[4-(5-CYANO-3-INDOLYL)BUTYL]-1-PIPERAZINYL)BENZOFURAN-2-CARBOXAMIDE SYNTHESIS METHOD | 2006 |
|
RU2397981C2 |
| CONDENSED BENZOCOMPOUND AND PHARMACEUTICAL COMPOSITION | 1993 |
|
RU2141959C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING, PREVENTING OR RELIEVING MOVEMENT DISORDERS AND ITS APPLICATION | 2011 |
|
RU2611376C2 |
| NOVEL ARYLPIPERAZINYL COMPOUNDS | 2004 |
|
RU2339627C2 |
| DERIVATIVES OF PIPERIDINE AND PIPERAZINE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITIONS CONTAINING ON SAID AND METHOD OF THEIR PREPARING | 1994 |
|
RU2132848C1 |
| NEW USING (R)-(-)-2-[5-(4-FLUOROPHENYL)-3-PYRIDYLMETHYLAMINOMETHYL]-CHROMAN AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS | 2001 |
|
RU2278663C2 |
| DERIVATIVES OF AMIDES AND UREA AS INHIBITORS OF REUPTAKE OF 5-HT AND LIGANDS OF 5-HT1B/1D | 1998 |
|
RU2211216C2 |
